
The year 2014 will end on a grim note for a number of people who have invested in Sharon Bio-Medicine and lost a large sum of money. We should take the opportunity to learn lessons from the episode so that we don’t have to suffer such losses again
Sharon Bio-Medicine’s savage fall of 20% yesterday appears to have shaken Daljeet Kohli. He has issued a terse note that he is investigating the cause of the fall and that the stock is “under review” till then
Daljeet Kohli continues to thrill the small investor. After a block-buster performance of 85% annualized gains from the Model Portfolio, Daljeet is back with a report on Top 10 stocks. As usual, his logic is simple and convincing
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments